173 related articles for article (PubMed ID: 24491425)
1. Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell origin.
Cesarman-Maus G; Braggio E; Lome-Maldonado C; Morales-Leyte AL; Fonseca R
Thromb Res; 2014 Apr; 133(4):606-9. PubMed ID: 24491425
[TBL] [Abstract][Full Text] [Related]
2. Absence of tissue factor expression by neoplastic plasma cells in multiple myeloma.
Cesarman-Maus G; Braggio E; Maldonado H; Fonseca R
Leukemia; 2012 Jul; 26(7):1671-4. PubMed ID: 22333877
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms.
Martin-Subero JI; Ammerpohl O; Bibikova M; Wickham-Garcia E; Agirre X; Alvarez S; Brüggemann M; Bug S; Calasanz MJ; Deckert M; Dreyling M; Du MQ; Dürig J; Dyer MJ; Fan JB; Gesk S; Hansmann ML; Harder L; Hartmann S; Klapper W; Küppers R; Montesinos-Rongen M; Nagel I; Pott C; Richter J; Román-Gómez J; Seifert M; Stein H; Suela J; Trümper L; Vater I; Prosper F; Haferlach C; Cruz Cigudosa J; Siebert R
PLoS One; 2009 Sep; 4(9):e6986. PubMed ID: 19750229
[TBL] [Abstract][Full Text] [Related]
4. Expression of tissue factor and tissue factor pathway inhibitor in microparticles and subcellular fractions of normal and malignant prostate cell lines.
Lwaleed BA; Lam L; Lasebai M; Cooper AJ
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):339-43. PubMed ID: 23524311
[TBL] [Abstract][Full Text] [Related]
5. Malignant lymphoma of mucosa-associated lymphoid tissue.
Isaacson PG; Spencer J
Histopathology; 1987 May; 11(5):445-62. PubMed ID: 3497084
[TBL] [Abstract][Full Text] [Related]
6. NF-κB pathways in hematological malignancies.
Gasparini C; Celeghini C; Monasta L; Zauli G
Cell Mol Life Sci; 2014 Jun; 71(11):2083-102. PubMed ID: 24419302
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Specific Silencing of Tissue Factor Suppresses Metastasis and Prevents Cancer-Associated Hypercoagulability.
Liu S; Zhang Y; Zhao X; Wang J; Di C; Zhao Y; Ji T; Cheng K; Wang Y; Chen L; Qi Y; Li S; Nie G
Nano Lett; 2019 Jul; 19(7):4721-4730. PubMed ID: 31180684
[TBL] [Abstract][Full Text] [Related]
8. Malignant lymphomas of the skin: their differentiation from lymphoid and nonlymphoid cutaneous infiltrates that simulate lymphoma.
Burke JS
Semin Diagn Pathol; 1985 Aug; 2(3):169-82. PubMed ID: 3916553
[TBL] [Abstract][Full Text] [Related]
9. Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis?
De Palma R; Cirillo P; Ciccarelli G; Barra G; Conte S; Pellegrino G; Pasquale G; Nassa G; Pacifico F; Leonardi A; Insabato L; Calì G; Golino P; Cimmino G
Int J Cardiol; 2016 Sep; 218():188-195. PubMed ID: 27236113
[TBL] [Abstract][Full Text] [Related]
10. Anti-PD-1-targeted therapies focusing on lymphatic malignancies: biological rationale, clinical challenges and opportunities.
Kedmi M; Avigdor A; Nagler A
Acta Haematol; 2015; 133(2):129-35. PubMed ID: 25247668
[TBL] [Abstract][Full Text] [Related]
11. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall.
Day SM; Reeve JL; Pedersen B; Farris DM; Myers DD; Im M; Wakefield TW; Mackman N; Fay WP
Blood; 2005 Jan; 105(1):192-8. PubMed ID: 15339841
[TBL] [Abstract][Full Text] [Related]
12. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature.
Bekkenk MW; Jansen PM; Meijer CJ; Willemze R
Ann Oncol; 2004 Jul; 15(7):1097-108. PubMed ID: 15205205
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis.
Seto S; Onodera H; Kaido T; Yoshikawa A; Ishigami S; Arii S; Imamura M
Cancer; 2000 Jan; 88(2):295-301. PubMed ID: 10640960
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic features of primary hepatic marginal zone lymphoma of mucosa-associated lymphoid tissue and hepatic pseudolymphoma].
Liu C; Li X; Li H; Gong QX; Li Y; Wang Z; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):39-44. PubMed ID: 29325249
[No Abstract] [Full Text] [Related]
15. Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.
Tinholt M; Vollan HK; Sahlberg KK; Jernström S; Kaveh F; Lingjærde OC; Kåresen R; Sauer T; Kristensen V; Børresen-Dale AL; Sandset PM; Iversen N
Breast Cancer Res; 2015 Mar; 17(1):44. PubMed ID: 25882602
[TBL] [Abstract][Full Text] [Related]
16. [Lymphatic system and differentiation of B and T lymphocytes].
Coupland SE; Hummel M; Stein H
Pathologe; 2000 Mar; 21(2):106-12. PubMed ID: 10840816
[TBL] [Abstract][Full Text] [Related]
17. Microparticles in Hematological Malignancies: Role in Coagulopathy and Tumor Pathogenesis.
Ball S; Nugent K
Am J Med Sci; 2018 Mar; 355(3):207-214. PubMed ID: 29549921
[TBL] [Abstract][Full Text] [Related]
18. Role of Tissue Factor in Tumor Progression and Cancer-Associated Thrombosis.
Rondon AMR; Kroone C; Kapteijn MY; Versteeg HH; Buijs JT
Semin Thromb Hemost; 2019 Jun; 45(4):396-412. PubMed ID: 31096312
[TBL] [Abstract][Full Text] [Related]
19. Benign lymphoid aggregates in the bone marrow: distribution patterns of B and T lymphocytes.
Naemi K; Brynes RK; Reisian N; Johnston A; Dhillon R; Walavalkar V; Zhao X; Rezk SA
Hum Pathol; 2013 Apr; 44(4):512-20. PubMed ID: 23063505
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies.
López-Pedrera C; Barbarroja N; Dorado G; Siendones E; Velasco F
Leukemia; 2006 Aug; 20(8):1331-40. PubMed ID: 16728982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
